Evidence map›Paper›PMID 40362453›Full record

ArticleInternational journal of molecular sciences2025

Silver Nanoparticle-Induced Nephrotoxicity in Zebrafish (

Grace Emily Okuthe, Busiswa Siguba

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Grace Emily OkutheDepartment of Biological & Environmental Sciences, Walter Sisulu University, P/B X1, Mthatha 5117, South Africa.ORCID 0000-0001-6357-6742
Busiswa SigubaDepartment of Biological & Environmental Sciences, Walter Sisulu University, P/B X1, Mthatha 5117, South Africa.

Funding

National Research Foundation South Africa UID: 99307
6 · The paper itself

Abstract

The escalating challenge of antibacterial resistance has driven the widespread use of silver nanoparticles (AgNPs) due to their potent antimicrobial properties. AgNPs can be synthesised through diverse methods, spanning conventional chemical and physical routes to the increasingly favoured biosynthesis approach. While offering environmental advantages, the ecological impact of biogenically synthesized AgNPs, especially on aquatic ecosystems, requires thorough evaluation. The renal system, critical for maintaining physiological homeostasis via nephron-mediated waste removal, fluid regulation, and electrolyte balance, is highly vulnerable to toxicant-induced damage, which can negatively affect organismal fitness. This study aimed to assess the nephrotoxic effects of AgNPs, synthesized using entirely "green" methods, on zebrafish after 96-h exposures to three distinct concentrations alongside a control group. Acridine orange fluorescence microscopy revealed dose-dependent histopathological alterations in renal tissues. Specifically, at 0.031 μg/L and 0.250 μg/L, significant changes were observed, including glomerular shrinkage, proliferation of hematopoietic tissue, dissociation and dilation of renal tubules, and melanomacrophage aggregation. At 5.000 μg/L, prolonged exposure beyond 48 h indicated a potential for renal tissue cell renewal, suggesting a possible compensatory response. These results demonstrate the sensitivity of zebrafish kidneys to AgNPs and emphasize the imperative for comprehensive in vivo toxicity testing, irrespective of synthesis method, to accurately evaluate the potential for adverse ecological impacts and ensure the preservation of aquatic ecosystem integrity.

Indexed as

KidneyMetal NanoparticlesSilverAnimalsZebrafishSilverbiosynthesishistopathologynephrotoxicityrenal systemsilver nanoparticles (AgNPs)Zebrafish

Identifiers

PMID40362453
PMCPMC12071903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.